統合失調症と急性精神病における抗精神病薬によるQT間隔の延長 - 前向きな研究
Anirban Saha1, Ajay Kumar1, Satyajit Singh2
1Department of Psychiatry, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
Industrial psychiatry journal
|August 27, 2025
まとめ
抗精神病薬はQT間隔 (QTIP) を延長し,心臓発作のリスクを増やす可能性があります. この研究は,統合失調症患者の7. 5%から15. 6%でQTIPを検出し,定期的な心臓モニタリングの必要性を強調しました.
科学分野:
- 精神科
- 心臓病科
- 薬理学について
背景:
- 抗精神病薬はQT間隔延長 (QTIP) と関連しており,Torsades de Pointesなどの潜在的に致命的な心律動乱や突然の心臓死のリスク要因です.
- QTIPの発生率と危険因子を理解することは,精神科医療における患者の安全性にとって極めて重要です.
研究 の 目的:
- 統合失調症と急性精神病の患者で2週間の抗精神病薬の使用後にQTIPの発生率を決定する.
- この患者集団におけるQTIPの発症に関連する潜在的な危険因子を特定する.
主な方法:
- 統合失調症または急性精神病と診断され,特定の含有/ 排除基準を満たした160人の成人患者群を研究した.
- 矯正されたQT間隔 (QTc) を計算するために,抗精神病薬治療の少なくとも2週間前と後に,心電図 (ECG) を実施した.
- QTIPは,フリデリシアの公式とバゼットの公式の両方を用いて,男性ではQTc> 450 ms,女性では> 460 msと定義された.
主要な成果:
- この研究では,平均年齢が35. 88歳で160人の患者が参加し,55%が男性,86. 3%が統合失調症でした.
- QTIPの発生率は7. 5% (フリデリシアの式) と15. 6% (バゼットの式) であった.
- 試験サンプルでは,QTIPの追加リスク要因は特定されなかった.
結論:
- QTIPは,抗精神病薬で治療された患者で顕著な懸念事項であり,参加者の有意な割合に影響します.
- QTIPのリスクを軽減するために,定期的なスクリーニングとリスク要因の慎重な評価は,抗精神病療法を受けている患者にとって不可欠です.
さらに関連する動画
05:52Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
15.0K
12:00Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization
Published on: November 19, 2014
13.0K
関連する概念動画
01:26Psychosis: Goals of Pharmacotherapy
209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209
01:28Psychosis and Antipsychotic Drugs: Overview
454
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
454
01:21Antipsychotic Drugs: Typical and Atypical Agents
314
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
314
01:24Mania and Antimanic Drugs: Overview
319
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
319
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
947
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
947
01:28Drug Therapy
97
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
97